Literature DB >> 15029043

[Macular damage in Behçet's disease].

O Benchekroun1, D Lahbil, H Lamari, R Rachid, M El Belhadji, N Laouissi, K Zaghloul, S Benamour, A Amraoui.   

Abstract

INTRODUCTION: The macular damage in Behçet's disease requires particular attention because of its poor prognosis.
PURPOSE: The purpose of our study was to specify the frequency of macular alterations in Behçet's disease and discuss the clinical, physiopathological and therapeutic aspects.
MATERIALS AND METHODS: Our report is based on 244 patients with Behçet's disease examined between January 1995 and December 1997. The authors studied macular alterations in detail.
RESULTS: Sixty-nine patients had a maculopathy affecting 108 out of 432 eyes (24%). The mean progression of Behçet's disease in these cases was 4 years. Visual acuity was<or=2/10e in 48 eyes (44.4%). Maculopathy was bilateral in 39 cases. Macular edema was the most frequently noted form in 62% of the eyes, followed by cystoid macular edema (17%) and macular hole (3.4%). DISCUSSION: Macular edema is the most frequent sign and complication arising from the macular area during Behçet's disease, which can evolve into cystoid degenerescence and occasionally macular hole. Macular lesions are often irreversible, making prognosis uncertain, despite the various treatments available.
CONCLUSION: Macular damage is the major cause of visual morbidity in patients with Behçet's disease and should be systematically sought.

Entities:  

Mesh:

Year:  2004        PMID: 15029043     DOI: 10.1016/s0181-5512(04)96110-4

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  8 in total

1.  Ocular manifestations of Behçet's disease in Jordanian patients.

Authors:  Mohammed A Abu-Ameerh; Sawsan F Mohammed; Mona T Mohammad; Osama H Ababneh; Muawyah D Al-Bdour
Journal:  Saudi J Ophthalmol       Date:  2013-07-01

2.  Macular involvement in patients with Behçet's uveitis.

Authors:  Rim Kahloun; Salim Ben Yahia; Samah Mbarek; Sonia Attia; Sonia Zaouali; Moncef Khairallah
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-05-02

3.  Macular hole in Behçet's disease.

Authors:  Hassan Al-Dhibi; Marwan Abouammoh; Essam Al-Harthi; Abdulrahman Al-Gaeed; Jorgen Larsson; Emad Abboud; Imtiaz Chaudhry
Journal:  Indian J Ophthalmol       Date:  2011 Sep-Oct       Impact factor: 1.848

4.  The Effect of Infliximab Therapy on Maculopathy in Behcet's Panuveitis: A Case Report.

Authors:  Ozlem G Sahin
Journal:  Case Rep Ophthalmol       Date:  2011-12-13

5.  [Epidemiological, clinical, therapeutic and evolutionary profile of ocular manifestations in patients with Behçet's disease].

Authors:  Amine Razzak; Anass Kassimi; Adil Mchachi; Leila Benhmidoune; Abderrahim Chakib; Rayad Rachid; Mohamed Elbelhadji; Abdelouahed Amraoui; Hassan Elkabli
Journal:  Pan Afr Med J       Date:  2019-06-14

6.  [Ophthalmologic manifestations of Behçet's disease, about 33 cases].

Authors:  Idriss Benatiya Andaloussi; Bouchra Alami; Meryem Abdellaoui; Salima Bhallil; Wafae Bono; Hicham Tahri
Journal:  Pan Afr Med J       Date:  2012-12-19

7.  Spontaneous closure of macular holes secondary to posterior uveitis: case series and a literature review.

Authors:  Nicolas Bonnin; Pierre-Loïc Cornut; Florian Chaise; Elodie Labeille; Helene Janin Manificat; Audrey Feldman; Laurent Perard; Franck Bacin; Frédéric Chiambaretta; Carole Burillon
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-02-11

8.  Vitreomacular Interface Disorders in Behçet's Uveitis.

Authors:  Hilal Eser Öztürk; Özlem Eşki Yücel; Yüksel Süllü
Journal:  Turk J Ophthalmol       Date:  2017-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.